183 related articles for article (PubMed ID: 24740103)
1. Association between the epidermal growth factor +61 G/A polymorphism and glioma risk: a meta-analysis.
Chen X; Yang G; Zhang D; Zhang W; Zou H; Zhao H; Zhang X; Zhao S
PLoS One; 2014; 9(4):e95139. PubMed ID: 24740103
[TBL] [Abstract][Full Text] [Related]
2. Quantitative assessment of the association between +61A>G polymorphism of epidermal growth factor gene and susceptibility to glioma.
Tao Y; Liang G
Tumour Biol; 2014 Jan; 35(1):369-77. PubMed ID: 23963773
[TBL] [Abstract][Full Text] [Related]
3. Association between EGF +61 G/A and glioma risk in a Chinese population.
Wang S; Zhao Y; Ruan Z; Chen H; Fan W; Chen J; Wu Q; Qian J; Zhang T; Huang Y; Lu D
BMC Cancer; 2010 May; 10():221. PubMed ID: 20487573
[TBL] [Abstract][Full Text] [Related]
4. Association between epidermal growth factor gene rs4444903 polymorphism and risk of glioma.
Hu M; Shi H; Xu Z; Liu W
Tumour Biol; 2013 Jun; 34(3):1879-85. PubMed ID: 23645212
[TBL] [Abstract][Full Text] [Related]
5. A functional +61G/A polymorphism in epidermal growth factor is associated with glioma risk among Asians.
Xu X; Xi L; Zeng J; Yao Q
PLoS One; 2012; 7(7):e41470. PubMed ID: 22829952
[TBL] [Abstract][Full Text] [Related]
6. Association between +61G polymorphism of the EGF gene and glioma risk in different ethnicities: a meta-analysis.
Tan D; Xu J; Li Y; Lai R
Tohoku J Exp Med; 2010 Dec; 222(4):229-35. PubMed ID: 21123997
[TBL] [Abstract][Full Text] [Related]
7. A functional polymorphism in the epidermal growth factor gene is associated with risk for glioma in a Chinese population.
Li Y; Zhao Y; Liu J; Liu P; Xu Y
Genet Test Mol Biomarkers; 2012 May; 16(5):449-52. PubMed ID: 22106858
[TBL] [Abstract][Full Text] [Related]
8. Association between functional EGF+61 polymorphism and glioma risk.
Costa BM; Ferreira P; Costa S; Canedo P; Oliveira P; Silva A; Pardal F; Suriano G; Machado JC; Lopes JM; Reis RM
Clin Cancer Res; 2007 May; 13(9):2621-6. PubMed ID: 17473192
[TBL] [Abstract][Full Text] [Related]
9. Association between epidermal growth factor +61 G/A polymorphism and glioma risk in a Chinese Han population.
Bao G; Wang M; Guo S; Han Y; Xu G
J Int Med Res; 2010; 38(5):1645-52. PubMed ID: 21309478
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms of EGF 5'-UTR and NAT2 857G/A associated with glioma in a case control study of Malaysian patients.
Muthusamy KA; Lian LH; Vairavan N; Chua KH; Waran V
Genet Mol Res; 2012 Aug; 11(3):2939-45. PubMed ID: 22782629
[TBL] [Abstract][Full Text] [Related]
11. No association between EGF +61 A/G polymorphism and increased risk of glioma.
Liu X; Li L; Chen X; Wang X; Mu L; Li Y; Xu Q; Xie Q; Lu F
Int J Biol Markers; 2009; 24(2):77-82. PubMed ID: 19634110
[TBL] [Abstract][Full Text] [Related]
12. Analysis of EGF+61A>G polymorphism and EGF serum levels in Brazilian glioma patients treated with perillyl alcohol-based therapy.
da Silveira Fd; Lopes Bde A; da Fonseca CO; Quirico-Santos T; de Palmer Paixão IC; de Amorim LM
J Cancer Res Clin Oncol; 2012 Aug; 138(8):1347-54. PubMed ID: 22481252
[TBL] [Abstract][Full Text] [Related]
13. Association between the EGF rs4444903 polymorphism and liver cancer susceptibility: a meta-analysis and meta-regression.
Li YL; Tian Z; Zhao L; Zhang CL
Genet Mol Res; 2014 Oct; 13(4):8066-79. PubMed ID: 25299191
[TBL] [Abstract][Full Text] [Related]
14. Associations between three XRCC1 polymorphisms and glioma risk: a meta-analysis.
Zhang H; Liu H; Knauss JL
Tumour Biol; 2013 Oct; 34(5):3003-13. PubMed ID: 23712607
[TBL] [Abstract][Full Text] [Related]
15. Association between GSTP1 Ile105Val polymorphism and glioma risk: a systematic review and meta-analysis.
Xie P; Liang Y; Liang G; Liu B
Tumour Biol; 2014 Jan; 35(1):493-9. PubMed ID: 23975366
[TBL] [Abstract][Full Text] [Related]
16. EGF+61 A>G polymorphism is not associated with lung cancer risk in the Brazilian population.
Laus AC; de Paula FE; de Lima MA; Carlos CD; Gomes INF; de Marchi P; Valente JKN; Pioltini ABM; Miziara JE; da Silva CM; Viana LS; Scapulatempo-Neto C; Reis RM
Mol Biol Rep; 2019 Apr; 46(2):2417-2425. PubMed ID: 30783937
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor gene polymorphism and risk of hepatocellular carcinoma: a meta-analysis.
Zhong JH; You XM; Gong WF; Ma L; Zhang Y; Mo QG; Wu LC; Xiao J; Li LQ
PLoS One; 2012; 7(3):e32159. PubMed ID: 22403631
[TBL] [Abstract][Full Text] [Related]
18. EGF +61A>G polymorphism and gastrointestinal cancer risk: a HuGE review and meta-analysis.
Piao Y; Liu Z; Ding Z; Xu L; Guo F; Sun Q; Xie X
Gene; 2013 Apr; 519(1):26-33. PubMed ID: 23403233
[TBL] [Abstract][Full Text] [Related]
19. Association study of an epidermal growth factor gene functional polymorphism with the risk and prognosis of gliomas in Brazil.
Pinto GR; Yoshioka FK; Clara CA; Santos MJ; Almeida JR; Burbano RR; Rey JA; Casartelli C
Int J Biol Markers; 2009; 24(4):277-81. PubMed ID: 20108217
[TBL] [Abstract][Full Text] [Related]
20. Association between the epidermal growth factor 61*A/G polymorphism and hepatocellular carcinoma risk: a meta-analysis.
Sun S; Jin GJ; Zhao Y; Kang H
Asian Pac J Cancer Prev; 2015; 16(7):3009-14. PubMed ID: 25854398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
